Article
Combination of Arsenic trioxide and Apatinib Synergistically Inhibits Small Cell Lung Cancer by Down-Regulating VEGFR2/mTOR and Akt/c-Myc Signaling Pathway via GRB10
2024-05-10
Abstract excerpt
<title>Abstract</title> <p>Background Small cell lung carcinoma (SCLC) is characterized by poor prognosis. High predilection for -metastasis, -proliferation, and absence of newer therapeutic options. Elucidation of newer pathways characterizing the disease may allow development targeted therapies and favorable outcomes. Methods Combinatorial action of arsenic trioxide (ATO) and apatinib (APA) were tested <itali...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f4d6fd58-79bf-586f-bfce-a2f4e20adbfc
- DOI
- 10.21203/rs.3.rs-4371733/v1
